Genomic Valley Biotech Ltd vs Mpil Corporation Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 25, 2026

Key Highlights

The Latest Trading Price of Genomic Valley Biotech Ltd is ₹ 26.99 as of 25 Mar 15:30 . The P/E Ratio of Genomic Valley Biotech Ltd changed from 694.2 on March 2024 to 50.1 on March 2025 . This represents a CAGR of -73.14% over 2 yearsThe P/E Ratio of MPIL Corporation Ltd changed from 105 on March 2021 to 0 on March 2025 . This represents a CAGR of -100.00% over 5 years The Market Cap of Genomic Valley Biotech Ltd changed from ₹ 10.6 crore on March 2024 to ₹ 17.9 crore on March 2025 . This represents a CAGR of 29.95% over 2 yearsThe Market Cap of MPIL Corporation Ltd changed from ₹ 15.98 crore on March 2021 to ₹ 38.58 crore on March 2025 . This represents a CAGR of 19.28% over 5 years The revenue of Genomic Valley Biotech Ltd for the Dec '25 is ₹ 0.05 crore as compare to the Sep '25 revenue of ₹ 0.09 crore. This represent the decline of -44.44% The revenue of MPIL Corporation Ltd for the Dec '25 is ₹ 0.38 crore as compare to the Sep '25 revenue of ₹ 0.39 crore. This represent the decline of -2.56% The ebitda of Genomic Valley Biotech Ltd for the Dec '25 is ₹ 0.01 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the growth of 9.2233718E16% The ebitda of MPIL Corporation Ltd for the Dec '25 is ₹ 0.16 crore as compare to the Sep '25 ebitda of ₹ 0.22 crore. This represent the decline of -27.27% The net profit of Genomic Valley Biotech Ltd changed from ₹ 0.13 crore to ₹ 0.01 crore over 7 quarters. This represents a CAGR of -76.91% The net profit of MPIL Corporation Ltd changed from ₹ 0.06 crore to ₹ 0.05 crore over 7 quarters. This represents a CAGR of -9.89% The Dividend Payout of Genomic Valley Biotech Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of MPIL Corporation Ltd changed from 45.6 % on March 2021 to -1.12 % on March 2025 . This represents a CAGR of NaN% over 5 years .

About Genomic Valley Biotech Ltd

Incorporated in May 1994, Genomic Valley Biotech Limited is formed with the objective of conducting research in the field of Biotechnology (Plant & Animal) and also to undertake commercial production of Plant Tissue Cultured Plants of different species to feed the genetically improved plant market nationally as well as internationally.
The Company is extensively involved in commercial greenhouse / poly house cultivation of crops.
Presently, it is engaged in high-tech cultivation through environmental controlled Poly Houses,NFT & DFT etc,manufacturing of Tissue Cultured Improved variety of plants and organic farming using Bio-Fertilizer.
Also it is involved in commercial Horticulture activities with Aloe vera, Tomato, Bitter Gourd, Bottle Gourd, Brinjal, Broccoli, Cabbage, Capsicum, Carrot, Cauliflower, Cucumber, Green Chillies, Onion, Radish, Ridge/Sponge Gourd, Leafy Vegetables, Pumpkin, Banana, Guava, Papaya, and Strawberry.

About MPIL Corporation Ltd

MPIL Corporation Limited was established in 1959 as Mather Greaves Private Limited.
In 1979, the name of the Company was changed to Mather and Platt (India) Limited and in 2006, the name of the Company was again changed to MPIL Corporation Limited.
The Company is in the business of providing support service and consultancy including Mergers & Acquisition. Mather & Platt (India), a member of Manu Chabria's Jumbo Group was originally promoted jointly by Mather & Platt, UK, and Greaves Cotton in Aug.'59 to set up a manufacturing facility to produce calenderbowls for textilie industry.
Later, the Company expanded its business operations and became one of the major player in the process machinery manufacturing in India.
It also engaged in manufacturing of pumps(centrifugal) and Fire protection Installations.

FAQs for the comparison of Genomic Valley Biotech Ltd and MPIL Corporation Ltd

Which company has a larger market capitalization, Genomic Valley Biotech Ltd or MPIL Corporation Ltd?

Market cap of Genomic Valley Biotech Ltd is 8 Cr while Market cap of MPIL Corporation Ltd is 20 Cr

What are the key factors driving the stock performance of Genomic Valley Biotech Ltd and MPIL Corporation Ltd?

The stock performance of Genomic Valley Biotech Ltd and MPIL Corporation Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Genomic Valley Biotech Ltd and MPIL Corporation Ltd?

As of March 25, 2026, the Genomic Valley Biotech Ltd stock price is INR ₹26.99. On the other hand, MPIL Corporation Ltd stock price is INR ₹364.8.

How do dividend payouts of Genomic Valley Biotech Ltd and MPIL Corporation Ltd compare?

To compare the dividend payouts of Genomic Valley Biotech Ltd and MPIL Corporation Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.